Financial Analysis
Historical Data
Financial Performance
Earnings Simulator
Adjust segment growth rates to model projected quarterly outcomes
Projected Total Revenue
฿1731M
Projected EBITDA Margin
27.4%
Projected EBITDA
฿474M
Fastest Growing Segment
Ampul
Segment Growth Rates
QoQ assumptionsRevenue Mix — Q3'25E
Quarterly Revenue by Segment
Historical + projected (฿M)
Blended EBITDA Margin
Historical + projected (%)
* Projected margins are model estimates only. EBITDA margin sensitivity assumes a 0.18pp margin expansion/contraction per 1% of quarterly growth rate adjustment.
Investor Relations
MADAME BIOSCIENCES
Financial & Valuation Report
Prepared: 30 September 2026
For internal and investor use only. For reference only. Not investment advice.
Investment Parameters
Valuation
Profitability
Efficiency
Growth
Financial Summary
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 50 | 55 | 65 | 79 | 100 |
| COGS | 30 | 35.75 | 42.9 | 54.51 | 55 |
| Gross Profits | 20 | 19.25 | 22.1 | 24.49 | 45 |
| %GP | 40% | 35% | 34% | 31% | 45% |
| SG&A | 10 | 12 | 11 | 12 | 14 |
| EBIT | 10 | 7.25 | 11.1 | 12.49 | 31 |
| %EBIT | 20% | 13% | 17% | 16% | 31% |
| Interests | 2 | 1 | 1 | 2 | 3 |
| Taxes | 4 | 3 | 2 | 1 | 4 |
| Net Profits | 4 | 3.25 | 8.1 | 9.49 | 24 |
| %NP | 8% | 6% | 12% | 12% | 24% |
| Growth | — | 81% | 249% | 117% | 253% |
Financial Charts
Revenue & Profit
- Revenue
- Gross Profits
- Net Profits
Profit Margins (%)
- %GP
- %NP
- %EBIT
P/E vs P/BV Peer Comparison — Valuation Positioning Map
| Company | Ticker | P/E (x) | P/BV (x) |
|---|---|---|---|
| Karmarts | KAMART | 13.3x | 2.48x |
| 88 (Thailand) | 88TH | 8.8x | 1.57x |
| Do Day Dream | DDD | 0.3x | 0.34x |
| Sector Average | 7.5x | 1.46x | |
Data sourced from public sources via AI. For reference only. Not investment advice.